Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.002Source: DataRank Database

A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease is a research paper published in Journal of Cystic Fibrosis (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.08)OA: bronzeTopics (50)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Paul Wasuwanich ORCID,Thammasin Ingviya ORCID,Alexandra Vasilescu,Kathryn A. Carson ORCID,Peter J. Mogayzel ORCID

Live enrichment

PubMed:32482593 OpenAlex:https://openalex.org/W3028981865

NCATS NIH HHS

Grant: UL1 TR001079

National Institutes of Health

NIH

FWCI

2.08

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.elsevier.com/tdm/userlicense/1.0/

journalhttp://www.cysticfibrosisjournal.com/article/S1569199320301338/pdf

publisherhttp://www.cysticfibrosisjournal.com/article/S1569199320301338/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1569199320301338?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1569199320301338?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcf.2020.05.002

Fields of Study

Cystic Fibrosis Research AdvancesLiver Disease and TransplantationInflammatory Biomarkers in Disease PrognosisAlanine TransaminaseAspartate AminotransferasesBiomarkersChild, PreschoolCystic FibrosisFemaleHumansLiver CirrhosisLiver Function TestsMaleMass ScreeningPlatelet CountPredictive Value of TestsSensitivity and SpecificitySeverity of Illness IndexUnited StatesYoung Adultgamma-Glutamyltransferase

MeSH Terms

Alanine TransaminaseAspartate AminotransferasesChild, PreschoolCystic FibrosisFemalegamma-GlutamyltransferaseHumansLiver CirrhosisLiver Function TestsMaleMass ScreeningPlatelet CountPredictive Value of TestsSensitivity and SpecificitySeverity of Illness IndexUnited StatesBiomarkersYoung Adult

Keywords

MedicineCystic fibrosisDiseaseLiver diseasePathologyInternal medicineBlood plateletsTransferasesLiver cirrhosisRespiratory Tract InfectionsBlood Chemical Analysis

Sustainable Development Goals

SDG 0: Good health and well-being